VIG
TEVA icon

Vienna Insurance Group’s Teva Pharmaceuticals TEVA Stock Holding History

Vienna Insurance Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-200,000
Closed -$7.25M – 26
2016
Q4 		$7.25M Buy
+200,000
New +$7.99M 5.6% 8

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Vienna Insurance Group's TEVA Position: Q1 2017 in Review

Vienna Insurance Group sold out of Teva Pharmaceuticals (TEVA) in Q1 2017, closing a stake of 200,000 shares — an estimated $7.25M sold.

Vienna Insurance Group first reported a position in TEVA in Q4 2016 and held it in 1 quarter. The position peaked at $7.25M in Q4 2016. 687 funds tracked by Wall St. Rank hold TEVA as of Q1 2017.

  • Vienna Insurance Group reported no remaining Teva Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Vienna Insurance Group sold 200,000 Teva Pharmaceuticals shares in Q1 2017, an estimated $7.25M.
  • Vienna Insurance Group first reported a position in Teva Pharmaceuticals in Q4 2016 and held it in 1 quarter.
  • Vienna Insurance Group's Teva Pharmaceuticals position peaked at $7.25M in Q4 2016.
  • 687 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2017.

Based on Vienna Insurance Group's 13F filing for Q1 2017, filed 4 Sep 2024.